Last updated 2026-07-23
- Raised $520k Series A, Mar 2025
- Raised $1.7M Seed round led by Merage institute, Jun 2023
- Raised $800k grant, Jun 2023
Total raised
$4.1M
Last: Undisclosed Round 2025-04
Stage
Seed
Founded
2018
Headcount
6
HQ
Raanana, Israel
Sector
Health Tech & Life Sciences
About
NeuroTrigger develops a wearable and lightweight muscle re-education system composed of a rechargeable stimulator and a pre-gelled Y-shaped electrode. This system delivers electrical pulses to muscles, facilitating and improving muscle performance, maintaining or increasing range of motion, and preventing or retarding disuse atrophy. The device is controlled by a mobile phone application via Bluetooth, allowing users, caregivers, or technicians to monitor and adjust stimulation parameters. The company has received FDA 510(k) clearance for its non-invasive muscle stimulation system (NTB) for general indications and is planning further clinical trials for specific claims like eyelid closure.
Funding history · 5 rounds · $4.1M total
2025-03
A Round
$520K
2023-06
Seed
$1.7M
★ Merage institute
2023-06
Grant
$800K
2021-12
Pre-Seed
$1.0M
2019-08
Grant
$100K
Headcount over time
From 4 (2020-12) to 6 (2024-10) · +2 (+50%) · 7 points · source: Finder history + radar grounding
Q&A
- What is NeuroTrigger's primary business?
- NeuroTrigger develops a wearable muscle re-education stimulator system designed to improve or facilitate muscle performance, maintain or increase range of motion, and prevent disuse atrophy.
- When was NeuroTrigger founded?
- NeuroTrigger was founded in June 2018.
- How many employees does NeuroTrigger currently have?
- NeuroTrigger has 1-10 employees.
- What is NeuroTrigger's total funding to date?
- NeuroTrigger has raised a total of $4,120,000 USD.
- When was NeuroTrigger's most recent funding round and what was the amount?
- NeuroTrigger's most recent funding round occurred in April 2025, raising $520,000 USD.
- Which investors participated in NeuroTrigger's July 2023 funding rounds?
- In July 2023, NeuroTrigger received funding from Merage Institute and a grant from BIRD Foundation.
- What regulatory approval has NeuroTrigger received for its product?
- NeuroTrigger has received FDA approval for its non-invasive muscle stimulation system (NTB).
- Who are the co-founders of NeuroTrigger?
- The co-founders of NeuroTrigger are Shachar Paz (Co-founder & CTO), Michal Marks (Co-founder & General Counsel), and Assaf Deutsch (Co-founder & VP R&D).
Team · 4
Michal Marks
Founder · Co-Founder, COO
Hagit Deutsch
Founder · Co-Founder
Shachar Paz
Founder · Co-Founder & CTO
Assaf Deutsch
Founder · Co-Founder, R&D Director
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical Devices
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2BB2C
Highlights
1 PatentsVerified
Tags
neuro-stimulationpatientsmedical-deviceswearablemedical-technologieswearablenon-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | nt-med.com/ |
|---|---|
| linkedin.com/company/69221549 | |
| facebook.com/neuro.trigger.7 |
Identifiers & details
| Legal name | NeuroTrigger Ltd. |
|---|---|
| Founded | 2018-6 |
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | nt-med.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515860047 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2018-06-14 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | תמר 3 אבן יהודה |